Use of liraglutide 3.0 mg for weight management in a real-world setting in Switzerland
District Judge Mark Pittman has approved the FDAs decision to remove semaglutide, the active ingredient in Ozempic and Wegovy, from its drug shortage list, dismissing a lawsuit filed by the Outsourcing Facilities Association
GLP1-RAs have proven non-inferiority the CVD outcomes
Use one patch daily for up to 8 hours
This inhibition consecutively leads to post-prandial GLP-1 plasma concentrations that are elevated 2-3-fold and mediates the glucose-dependent stimulation of insulin secretion and inhibition of glucagon secretion (Table 1 gives a summary of the clinical phase III studies with at least 52 weeks duration on the efficacy of DPP-4 inhibitors compared to sulfonylureas as add on therapy to metformin, respectively, in patients not reaching their glycaemic goals with a monotherapy of metformin
Leading companies such as Novo Nordisk, Eli Lilly, and Sanofi have contributed to market growth with innovative products, including once-weekly formulations to improve patient adherence
